Person-Centered Care Approaches to the Treatment of Patients With Neuropsychiatric Manifestations of Parkinson’s Disease (CME/CE Symposium)

Activity Description

This case-based symposium will provide a systematic approach to managing patients with Parkinson’s disease and comorbid conditions, such as dementia, anxiety, psychosis, depression, and anxiety.

Target Audience

This educational activity is intended for psychiatric clinicians, including physicians, physician assistants, nurse practitioners, and nurses, caring for patients with Parkinson’s disease

Learning Objectives

After completing this activity, participants will be better able to:

  • Describe the use of behavioral management strategies to manage neuropsychiatric aspects of Parkinson’s disease
  • Develop evidence-based treatment strategies for patients with Parkinson’s disease and comorbid neuropsychiatric conditions (eg, Parkinson’s disease psychosis, Parkinson’s disease dementia, depression, anxiety, and agitation)
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC
  • 1.50 Participation
Course opens: 
03/05/2023
Course expires: 
03/05/2023

Faculty

George T. Grossberg, MD (Chair)
Samuel W. Fordyce Professor
Director, Geriatric Psychiatry
Department of Psychiatry and Behavioral Neuroscience
Saint Louis University School of Medicine
St Louis, Missouri

Danielle Larson, MD
Movement Disorders Specialist
Ken and Ruth Davee Department of Neurology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Gary Small, MD
Chair of Psychiatry
Hackensack University Medical Center
Physician-in-Chief, Behavioral Health
H. Hovnanian Family Foundation Chair
Hackensack Meridian Health
Professor of Psychiatry and Behavioral Health
Hackensack Meridian School of Medicine
Hackensack, New Jersey

Disclosure Policy

MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.

Faculty

George T. Grossberg, MD, is a consultant for ACADIA Pharmaceuticals Inc, Alkahest, Inc, Avanir Pharmaceuticals, Inc, Axsome Therapeutics, Inc, Biogen Idec, BioXcel Therapeutics, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Genentech, Inc, H Lundbeck A/S, Karuna Therapeutics, Otsuka America Pharmaceutical, Inc, and Takeda Pharmaceuticals USA, Inc; is a contracted researcher for F. Hoffmann-La Roche Ltd, Janssen Pharmaceuticals, Inc, and Nia Therapeutics; and is on the safety monitoring committee of Anavex Life Sciences Corp, EryDel SPA, Intra-Cellular Therapies, Inc, Merck & Co., Inc, and Newron Pharmaceuticals SPA.

Danielle Larson, MD, is an advisory board member of Kyowa Kirin Co, Ltd.

Gary Small, MD, is a consultant for Eli Lilly and Company, Handok Inc, and Theravalues; is an advisory board member of ACADIA Pharmaceuticals Inc, Biogen Idec, Corium, Inc, F. Hoffmann-La Roche Ltd, H Lundbeck*, Herbalife International of America, Inc, McCormick Science Institute, Otsuka America Pharmaceutical, Inc, and Reckitt Benckiser Group PLC; and has stock options in CereMark Pharma that have not been exercised.

* The financial relationship existed during the last 24 months but has now ended.

Peer Reviewers

This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.

Planners, Managers, and Writers

Carrie Allen, PharmD, BCPP, BCPS, MedEdicus Content Manager for this activity, was previously employed by CVS within the past 2 years, but that relationship has ended.

Other MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. You must attend the entire symposium as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.  

For Physicians

ACCME Accreditation Statement

MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Credit Designation Statement

MedEdicus LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Nurses

Interprofessional Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by MedEdicus LLC and Amedco LLC. Amedco LLC is jointly accredited by the ACCME, the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.

Nurses (ANCC) Credit Designation

Amedco LLC designates this activity for a maximum of 1.5 ANCC contact hours.

Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.

Disclosure of Commercial Support

This continuing medical education activity is supported through an educational grant from ACADIA Pharmaceuticals Inc.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco LLC, or ACADIA Pharmaceuticals Inc.

©2023 MedEdicus LLC. 292.2

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC
  • 1.50 Participation
Please login or register to take this course.

Click Take course to proceed to the evaluation and to obtain your certificate.